Previous efforts for developing recombinant tetravalent
EDIII vaccines used different approaches.
All four candidate tetravalent
vaccines were found to be safe, and no participants experienced fever or dengue-like illness after vaccination.
In a study published last year, more than 20,000 parents were surveyed in 2009 on their adolescent's immunization status for three vaccines: tetanus/diphtheria or tetatnus/diphtheria/pertussis (Td/Tdap), tetravalent
meningitis (MenACWY) and human papillomavirus (HPV).
Meningococcal polysaccharide vaccines are available in either bivalent (groups A and C), trivalent (groups A, C and W), or tetravalent
(groups A, C, Y and W135) forms to control the disease.
Later in 2006 GAVI introduced tetravalent
vaccine (DPT with Hepatitis B) and thus the vaccination schedule moved to 6, 10 and 14 weeks.
AFRIMS researchers have partnered with Sanofi Pasteur to test ChimeriVax, a tetravalent
vaccine against all four strains of dengue.
Dr Fikri also said that based on World Health Organisation recommendations, the ministry is also considering new vaccines such as for Rotavirus (severe diarrhea), Cervical Cancer, Acellular Tetravalent
(Diptheria-Tetaus) and Varicella (Chickenpox).
Long term effects of vaccination of patients deficient in a late complement component with a tetravalent
meningococcal polysaccharide vaccine.
In a typical process to form an allylic titanate, an allylic alcohol is reacted with titanium tetravalent
salt, where the suitable ligands are selected from alkoxides.
This Phase 1 study will also prepare us for the initial clinical testing of Hawaii Biotech's tetravalent
The second article on infectious diseases highlights one of the more critical unmet needs in global health: the creation of a tetravalent
vaccine for dengue.
University of Dayton, Dayton, Ohio has received a patent for solid corrosion-inhibiting conversion coating formed on a substrate metal, the conversion coating is comprised of a rare earth element and an inorganic valence stabilizer combined to form a rare earth/valence stabilizer complex within the solid corrosion-inhibiting conversion coating, wherein the rare earth element is selected from cerium, praseodymium, terbium, or a combination thereof, and at least one rare earth element is in the tetravalent
oxidation state in the rare earth/valence stabilizer complex in the solid corrosion-inhibiting conversion coating.